NeuroMetrix Stock Price, News & Analysis (NASDAQ:NURO)

$1.68 0.00 (0.00 %)
(As of 12/12/2017 02:40 PM ET)
Previous Close$1.68
Today's Range$1.62 - $1.77
52-Week Range$1.45 - $9.60
Volume82,400 shs
Average Volume84,041 shs
Market Capitalization$3.94 million
P/E RatioN/A
Dividend YieldN/A
Beta0.33

About NeuroMetrix (NASDAQ:NURO)

NeuroMetrix logoNeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Receive NURO News and Ratings via Email

Sign-up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NURO
CUSIPN/A
Phone781-890-9989

Debt

Debt-to-Equity RatioN/A
Current Ratio1.93%
Quick Ratio1.52%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$12.03 million
Price / Sales0.33
Cash FlowN/A
Price / CashN/A
Book Value$5.58 per share
Price / Book0.30

Profitability

Trailing EPS($17.04)
Net Income$-14,910,000.00
Net Margins-80.57%
Return on Equity-232.71%
Return on Assets-140.16%

Miscellaneous

Employees44
Outstanding Shares2,350,000

NeuroMetrix (NASDAQ:NURO) Frequently Asked Questions

What is NeuroMetrix's stock symbol?

NeuroMetrix trades on the NASDAQ under the ticker symbol "NURO."

When did NeuroMetrix's stock split? How did NeuroMetrix's stock split work?

NeuroMetrix's stock reverse split before market open on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 11th 2017. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split.

How were NeuroMetrix's earnings last quarter?

NeuroMetrix, Inc. (NASDAQ:NURO) posted its quarterly earnings results on Thursday, July, 21st. The medical device company reported ($42.96) earnings per share for the quarter, missing analysts' consensus estimates of ($7.44) by $35.52. The medical device company had revenue of $2.65 million for the quarter, compared to the consensus estimate of $1.22 million. NeuroMetrix had a negative return on equity of 232.71% and a negative net margin of 80.57%. View NeuroMetrix's Earnings History.

Where is NeuroMetrix's stock going? Where will NeuroMetrix's stock price be in 2017?

1 analysts have issued 1 year price objectives for NeuroMetrix's shares. Their predictions range from $3.00 to $3.00. On average, they anticipate NeuroMetrix's stock price to reach $3.00 in the next year. View Analyst Ratings for NeuroMetrix.

Who are some of NeuroMetrix's key competitors?

Who are NeuroMetrix's key executives?

NeuroMetrix's management team includes the folowing people:

  • Shai N. Gozani M.D., Ph.D., Chairman of the Board, President, Chief Executive Officer, Secretary (Age 52)
  • Thomas T. Higgins, Chief Financial Officer, Senior Vice President, Treasurer (Age 65)
  • Francis X. McGillin, Senior Vice President, Chief Commercial Officer (Age 56)
  • David E. Goodman M.D., Independent Director (Age 61)
  • Nancy E. Katz, Independent Director (Age 58)
  • Timothy R. Surgenor, Independent Director (Age 57)
  • David Van Avermaete, Independent Director (Age 65)

How do I buy NeuroMetrix stock?

Shares of NeuroMetrix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NeuroMetrix's stock price today?

One share of NeuroMetrix stock can currently be purchased for approximately $1.68.

How big of a company is NeuroMetrix?

NeuroMetrix has a market capitalization of $3.94 million and generates $12.03 million in revenue each year. The medical device company earns $-14,910,000.00 in net income (profit) each year or ($17.04) on an earnings per share basis. NeuroMetrix employs 44 workers across the globe.

How can I contact NeuroMetrix?

NeuroMetrix's mailing address is 1000 WINTER STREET, WALTHAM MA, 02451. The medical device company can be reached via phone at 781-890-9989 or via email at [email protected]


MarketBeat Community Rating for NeuroMetrix (NURO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about NeuroMetrix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NeuroMetrix (NASDAQ:NURO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $19.50$19.50$26.00$26.00
Price Target Upside: 1,033.72% upside1,033.72% upside758.09% upside758.09% upside

NeuroMetrix (NASDAQ:NURO) Consensus Price Target History

Price Target History for NeuroMetrix (NASDAQ:NURO)

NeuroMetrix (NASDAQ:NURO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/20/2017HC WainwrightReiterated RatingBuy$10.00 -> $3.00N/AView Rating Details
10/21/2016Rodman & RenshawReiterated RatingBuy$36.00N/AView Rating Details
2/29/2016Dawson JamesReiterated RatingBuyN/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

NeuroMetrix (NASDAQ:NURO) Earnings History and Estimates Chart

Earnings by Quarter for NeuroMetrix (NASDAQ:NURO)

NeuroMetrix (NASDAQ NURO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/20/2017Q2 2017($2.83)($2.49)$4.40 million$4.31 millionViewN/AView Earnings Details
4/20/2017Q1 2017($3.92)($7.28)$4.17 million$4.31 millionViewN/AView Earnings Details
1/26/2017Q416($6.00)($4.16)$3.48 million$3.70 millionViewListenView Earnings Details
10/20/2016Q316($6.56)($6.08)$3.01 million$3.39 millionViewListenView Earnings Details
7/21/2016Q216($7.44)($42.96)$1.22 million$2.65 millionViewListenView Earnings Details
4/21/2016Q116($7.60)($8.00)$2.65 million$2.28 millionViewListenView Earnings Details
10/22/2015Q315($0.64)($2.08)$6.47 million$2.10 millionViewListenView Earnings Details
7/22/2015Q215($3.84)$9.80 million$1.22 millionViewListenView Earnings Details
2/12/2015Q414($2.88)$4.62 million$1.41 millionViewN/AView Earnings Details
7/24/2014Q413($6.80)$1.16 million$1.34 millionViewN/AView Earnings Details
2/13/2014($6.96)ViewListenView Earnings Details
10/23/2013Q313($2.08)$1.77 million$1.31 millionViewListenView Earnings Details
7/25/2013Q2 2013($7.36)$2.20 million$1.20 millionViewN/AView Earnings Details
2/3/2011($1.36)($1.44)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

NeuroMetrix (NASDAQ:NURO) Earnings Estimates

Next Year EPS Consensus Estimate: $-4.5 EPS

Dividends

Dividend History for NeuroMetrix (NASDAQ:NURO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

NeuroMetrix (NASDAQ NURO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.40%
Institutional Ownership Percentage: 11.96%
Insider Trades by Quarter for NeuroMetrix (NASDAQ:NURO)
Insider Trades by Quarter for NeuroMetrix (NASDAQ:NURO)

NeuroMetrix (NASDAQ NURO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/11/2017Shai GozaniCEOBuy2,000$1.70$3,400.00View SEC Filing  
12/7/2017Shai GozaniCEOBuy6,333$1.50$9,499.50View SEC Filing  
12/7/2017Thomas T HigginsCFOBuy2,000$1.51$3,020.00View SEC Filing  
12/1/2017Shai GozaniCEOBuy3,000$1.70$5,100.00View SEC Filing  
11/16/2017Shai GozaniCEOBuy2,000$1.94$3,880.00View SEC Filing  
10/25/2017Shai GozaniCEOBuy5,000$1.67$8,350.00View SEC Filing  
10/25/2017Thomas T HigginsInsiderBuy2,500$1.70$4,250.00View SEC Filing  
10/23/2017Thomas T HigginsInsiderBuy2,500$1.77$4,425.00View SEC Filing  
6/21/2017Thomas T HigginsInsiderBuy1,000$2.83$2,830.00View SEC Filing  
6/16/2017Shai GozaniCEOBuy3,500$2.90$10,150.00View SEC Filing  
6/15/2017Thomas T HigginsInsiderBuy3,500$2.98$10,430.00View SEC Filing  
6/14/2017Shai GozaniCEOBuy5,000$2.97$14,850.00View SEC Filing  
6/14/2017Thomas T HigginsInsiderBuy2,300$2.97$6,831.00View SEC Filing  
11/1/2016Shai GozaniCEOBuy3,000$1.31$3,930.00View SEC Filing  
10/28/2016Thomas T HigginsInsiderBuy3,000$1.32$3,960.00View SEC Filing  
10/27/2016Shai GozaniCEOBuy6,000$1.32$7,920.00View SEC Filing  
8/31/2016Thomas T HigginsCFOBuy1,400$1.41$1,974.00View SEC Filing  
8/18/2016Shai GozaniCEOBuy5,000$1.49$7,450.00View SEC Filing  
8/12/2016Thomas T HigginsInsiderBuy2,000$1.45$2,900.00View SEC Filing  
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

NeuroMetrix (NASDAQ NURO) News Headlines

Source:
DateHeadline
NeuroMetrix (NURO) Announces New U.S. Patent for Quell Wearable TechnologyNeuroMetrix (NURO) Announces New U.S. Patent for Quell Wearable Technology
www.streetinsider.com - November 30 at 10:52 AM
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable TechnologyNeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
finance.yahoo.com - November 29 at 10:19 AM
Contrasting NeuroMetrix (NURO) & Bio-Rad Laboratories (BIO)Contrasting NeuroMetrix (NURO) & Bio-Rad Laboratories (BIO)
www.americanbankingnews.com - November 19 at 1:08 AM
Interested In The Healthcare Industry? Take A Look At NeuroMetrix Inc (NURO)Interested In The Healthcare Industry? Take A Look At NeuroMetrix Inc (NURO)
finance.yahoo.com - November 18 at 9:04 AM
Comparing NeuroMetrix (NURO) and LDR Holding Corp (LDRH)Comparing NeuroMetrix (NURO) and LDR Holding Corp (LDRH)
www.americanbankingnews.com - November 15 at 11:24 PM
What Is NeuroMetrix Inc’s (NURO) Share Price Doing?What Is NeuroMetrix Inc’s (NURO) Share Price Doing?
finance.yahoo.com - November 2 at 7:06 AM
NeuroMetrix Closes $3.5 Million Equity OfferingNeuroMetrix Closes $3.5 Million Equity Offering
finance.yahoo.com - November 1 at 7:05 AM
-$1.60 EPS Expected for NeuroMetrix, Inc. (NURO) This Quarter-$1.60 EPS Expected for NeuroMetrix, Inc. (NURO) This Quarter
www.americanbankingnews.com - October 27 at 5:30 AM
NeuroMetrix (NURO) vs. Integra LifeSciences Holdings Corporation (IART) Head-To-Head SurveyNeuroMetrix (NURO) vs. Integra LifeSciences Holdings Corporation (IART) Head-To-Head Survey
www.americanbankingnews.com - October 26 at 7:58 AM
NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q3, 2017 By the Numbers : October 24, 2017NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q3, 2017 By the Numbers : October 24, 2017
finance.yahoo.com - October 25 at 8:24 AM
Comparing K2M Group Holdings (KTWO) & NeuroMetrix (NURO)Comparing K2M Group Holdings (KTWO) & NeuroMetrix (NURO)
www.americanbankingnews.com - October 22 at 6:22 AM
NeuroMetrix, Inc. (NURO) Given Buy Rating at HC WainwrightNeuroMetrix, Inc. (NURO) Given Buy Rating at HC Wainwright
www.americanbankingnews.com - October 21 at 2:22 PM
NeuroMetrix Reports Q3 2017 Financial ResultsNeuroMetrix Reports Q3 2017 Financial Results
finance.yahoo.com - October 20 at 6:58 AM
Edited Transcript of NURO earnings conference call or presentation 19-Oct-17 12:00pm GMTEdited Transcript of NURO earnings conference call or presentation 19-Oct-17 12:00pm GMT
finance.yahoo.com - October 20 at 6:58 AM
Head to Head Review: NeuroMetrix (NURO) vs. Landauer (LDR)Head to Head Review: NeuroMetrix (NURO) vs. Landauer (LDR)
www.americanbankingnews.com - October 12 at 4:32 AM
NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference CallNeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call
finance.yahoo.com - October 11 at 5:06 AM
NeuroMetrix, Inc. (NURO) Set to Announce Earnings on WednesdayNeuroMetrix, Inc. (NURO) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 11 at 1:56 AM
Financial Survey: NeuroMetrix (NURO) vs. The CompetitionFinancial Survey: NeuroMetrix (NURO) vs. The Competition
www.americanbankingnews.com - September 23 at 12:26 AM
Head to Head Contrast: Tandem Diabetes Care (TNDM) versus NeuroMetrix (NURO)Head to Head Contrast: Tandem Diabetes Care (TNDM) versus NeuroMetrix (NURO)
www.americanbankingnews.com - September 19 at 12:56 PM
Before You Buy NeuroMetrix Inc’s (NURO), You Should Consider ThisBefore You Buy NeuroMetrix Inc’s (NURO), You Should Consider This
finance.yahoo.com - September 19 at 5:44 AM
NeuroMetrix (NURO) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - SlideshowNeuroMetrix (NURO) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 12 at 7:16 AM
Comparing Asante Solutions (PUMP) & NeuroMetrix (NURO)Comparing Asante Solutions (PUMP) & NeuroMetrix (NURO)
www.americanbankingnews.com - September 9 at 6:44 PM
Syneron Medical (ELOS) vs. NeuroMetrix (NURO) Financial AnalysisSyneron Medical (ELOS) vs. NeuroMetrix (NURO) Financial Analysis
www.americanbankingnews.com - September 8 at 10:28 PM
NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017
finance.yahoo.com - September 6 at 7:02 AM
Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National ConferenceTwo Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference
finance.yahoo.com - September 1 at 6:31 AM
NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic PainNeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain
finance.yahoo.com - August 30 at 7:25 AM
Comparing Asante Solutions (PUMP) and NeuroMetrix (NURO)Comparing Asante Solutions (PUMP) and NeuroMetrix (NURO)
www.americanbankingnews.com - August 17 at 4:50 AM
NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During SleepNeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep
finance.yahoo.com - August 15 at 4:32 PM
NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in JapanNeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan
finance.yahoo.com - August 4 at 6:27 AM
NeuroMetrix Announces Shipment of 100000 - Business Wire (press release)NeuroMetrix Announces Shipment of 100000 - Business Wire (press release)
www.businesswire.com - July 29 at 5:41 AM
NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015
finance.yahoo.com - July 28 at 6:18 AM
NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2017 By the Numbers : July 24, 2017NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2017 By the Numbers : July 24, 2017
finance.yahoo.com - July 25 at 6:19 AM
NeuroMetrix Reports Q2 2017 Financial Results - Business Wire (press release)NeuroMetrix Reports Q2 2017 Financial Results - Business Wire (press release)
www.businesswire.com - July 22 at 7:05 AM
NeuroMetrix, Inc. (NURO) Announces  Earnings ResultsNeuroMetrix, Inc. (NURO) Announces Earnings Results
www.americanbankingnews.com - July 21 at 11:05 AM
Investor Network: NeuroMetrix, Inc. to Host Earnings CallInvestor Network: NeuroMetrix, Inc. to Host Earnings Call
finance.yahoo.com - July 21 at 4:30 AM
NeuroMetrix Reports Q2 2017 Financial ResultsNeuroMetrix Reports Q2 2017 Financial Results
finance.yahoo.com - July 21 at 4:30 AM
Edited Transcript of NURO earnings conference call or presentation 20-Jul-17 12:00pm GMTEdited Transcript of NURO earnings conference call or presentation 20-Jul-17 12:00pm GMT
finance.yahoo.com - July 21 at 4:30 AM
NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call - Business Wire (press release)NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call - Business Wire (press release)
www.businesswire.com - July 13 at 7:27 AM
NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference CallNeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call
finance.yahoo.com - July 13 at 7:27 AM
NeuroMetrix, Inc. (NURO)NeuroMetrix, Inc. (NURO)
seekingalpha.com - July 12 at 6:30 AM
NeuroMetrix Announces $7.0 Million Private Placement of Preferred StockNeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock
finance.yahoo.com - July 11 at 6:04 AM
NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of DiagnosticsNeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics
finance.yahoo.com - July 6 at 7:35 AM
NeuroMetrix Provides Update on Quell Health Cloud Including ... - Business Wire (press release)NeuroMetrix Provides Update on Quell Health Cloud Including ... - Business Wire (press release)
www.businesswire.com - June 27 at 6:49 AM
NeuroMetrix (NURO) Presents At 7th Annual LD Micro Invitational Conference - SlideshowNeuroMetrix (NURO) Presents At 7th Annual LD Micro Invitational Conference - Slideshow
seekingalpha.com - June 9 at 7:07 PM
NeuroMetrix (NURO) Says Preliminary Results from Study Evaluating Quell in Chemotherapy-Induced Peripheral Neuropathy to be Presented at APS MeetingNeuroMetrix (NURO) Says Preliminary Results from Study Evaluating Quell in Chemotherapy-Induced Peripheral Neuropathy to be Presented at APS Meeting
www.streetinsider.com - May 16 at 10:10 AM
NeuroMetrix (NURO) Declares 1-for-8 Reverse Stock SplitNeuroMetrix (NURO) Declares 1-for-8 Reverse Stock Split
www.streetinsider.com - May 13 at 8:20 AM
NeuroMetrix (NURO) Announces Expansion of International Intellectual Property Assets for QuellNeuroMetrix (NURO) Announces Expansion of International Intellectual Property Assets for Quell
www.streetinsider.com - May 8 at 6:24 PM
NeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief TechnologyNeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology
www.businesswire.com - May 8 at 12:15 PM
NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call - Business Wire (press release)NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call - Business Wire (press release)
www.businesswire.com - April 12 at 7:51 PM
NEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersNEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - February 28 at 6:59 PM

SEC Filings

NeuroMetrix (NASDAQ:NURO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

NeuroMetrix (NASDAQ:NURO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

NeuroMetrix (NASDAQ NURO) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.